²ÝÁñ2024еس¶Ò»¶þ

Discover Viatris

Same Company, Different Operating System: Carlos’ Neurodiverse Journey

Access & Impact

²ÝÁñ2024еس¶Ò»¶þPublishes 2024 Sustainability Report: Building Sustainable Access at Scale

Discover Viatris

²ÝÁñ2024еس¶Ò»¶þAnnounces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions

Discover Viatris

²ÝÁñ2024еس¶Ò»¶þAnnounces Positive Results from Phase 3 Study of Investigational XULANE LOâ„¢ Low Dose Patch for Birth Control in Women of Childbearing Potential